Evidence map›Paper›PMID 29201555›Full record

ArticleBrain and behavior2017

Background and distribution of lobar microbleeds in cognitive dysfunction.

Hirofumi Matsuyama, Yuichiro Ii, Masayuki Maeda, Maki Umino, Yukito Ueda, Ken-Ichi Tabei, Hirotaka Kida, Masayuki Satoh, Akihiro Shindo, Akira Taniguchi and 2 more

Abstract read
In one paragraph

Article in Brain and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hirofumi MatsuyamaDepartment of Neurology Mie University Graduate School of Medicine Tsu Mie Japan.ORCID 0000-0002-9137-562X
Yuichiro IiDepartment of Neurology Mie University Graduate School of Medicine Tsu Mie Japan.
Masayuki MaedaDepartment of Advanced Diagnostic Imaging Mie University Graduate School of Medicine Tsu Mie Japan.
Maki UminoDepartment of Radiology Mie University Graduate School of Medicine Tsu Mie Japan.
Yukito UedaDepartment of Rehabilitation Mie University Hospital Tsu Mie Japan.
Ken-Ichi TabeiDepartment of Dementia Prevention and Therapeutics Mie University Graduate School of Medicine Tsu Mie Japan.
Hirotaka KidaDepartment of Dementia Prevention and Therapeutics Mie University Graduate School of Medicine Tsu Mie Japan.
Masayuki SatohDepartment of Dementia Prevention and Therapeutics Mie University Graduate School of Medicine Tsu Mie Japan.
Akihiro ShindoDepartment of Neurology Mie University Graduate School of Medicine Tsu Mie Japan.ORCID 0000-0002-1006-4943
Akira TaniguchiDepartment of Neurology Mie University Graduate School of Medicine Tsu Mie Japan.
Ryosuke TakahashiDepartment of Neurology Kyoto University Graduate School of Medicine Kyoto Japan.
Hidekazu TomimotoDepartment of Neurology Mie University Graduate School of Medicine Tsu Mie Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Cerebral microbleeds (CMBs) are often observed in memory clinic patients. It has been generally accepted that deep CMBs (D-CMBs) result from hypertensive vasculopathy (HV), whereas strictly lobar CMBs (SL-CMBs) result from cerebral amyloid angiopathy (CAA) which frequently coexists with Alzheimer's disease (AD). Mixed CMBs (M-CMBs) have been partially attributed to HV and also partially attributed to CAA. The aim of this study was to elucidate the differences between SL-CMBs and M-CMBs in terms of clinical features and regional distribution. Materials: We examined 176 sequential patients in our memory clinic for clinical features and CMB location using susceptibility-weighted images obtained on a 3T-MRI. The number of lobar CMBs in SL-CMBs and M-CMBs was counted in each cerebral lobe and their regional density was adjusted according to the volume of each lobe. Results: Of the total 176 patients, 111 patients (63.1%) had CMBs. Within the patients who had CMBs, M-CMBs were found in 54 patients (48.6%), followed by SL-CMBs in 35 (31.5%) and D-CMBs in 19 (17.1%). The SL-CMB group showed a significantly higher prevalence of family history of dementia, whereas the M-CMB group showed an increasing trend toward hypertension and smoking. The prevalence of AD was significantly higher in the SL-CMBs group, whereas the prevalence of AD with cerebrovascular disease was higher in the M-CMBs group. The regional density of lobar CMBs was significantly higher in the occipital lobe in the M-CMB group, whereas the SL-CMB group showed higher regional density between regions an increasing tendency in the parietal and occipital lobe. Conclusion: The between-group differences in clinical features and regional distribution indicate there to be an etiological relationship of SL-CMBs to AD and CAA, and M-CMBs to both HV and CAA.

Indexed as

Alzheimer DiseaseCerebral Amyloid AngiopathyCerebral HemorrhageHypertensionAgedCognitive DysfunctionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedStatistics as Topiccerebral amyloid angiopathycerebral microbleedshypertensive vasculopathymagnetic resonance imagingmemory clinic

Identifiers

PMID29201555
PMCPMC5698872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.